Organic compounds and their uses

US8445527B2 · kind B2 · utility

Assignee

• Novartis AG · CH

Inventors

• Michael A. Patane · Harleysville, US
• Prakash Raman · Acton, US
• David Thomas Parker · Cambridge, US
• Jiping Fu · Danville, US
• Branko Radetich · Boston, US
• Mohindra Seepersaud · Cambridge, US
• Aregahegn Yifru · Benicia, US
• Rui Zheng · Arlington, US
• Trixi Brandl · Biberach, DE
• Francois Lenoir · Waltham, US
• Pascal Rigollier · Mulhouse, FR
• Oliver Simic · Basel, CH

Key dates

• Filing date: May 22, 2012
• Grant date: May 21, 2013
• Expiry date: May 22, 2032

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides a method of treating a HCV infection in a subject in need thereof by administering a compound of Formula I:or pharmaceutically acceptable salts thereof or stereoisomers thereof.